Page 180 - Mployee Wellness Programs News Today

In 2021, 69% of LGBQ+ teens reported experiencing persistent feelings of sadness or hopelessness in the past year, compared to 35% of heterosexual teens, according to a recent CDC report. This stat is likely understated because the report did not include information about those who identify as transgender, experts said.

Optimizing drug routines allows prescribers to make more informed decisions that reduce risk and improve quality of care. The result is better outcomes for both patients and organizations.

NLP in healthcare can accurately give voice to the massive amount of unstructured data of the healthcare universe, and here are the three reasons why I believe 2023 is the year that we will see increased adoption of NLP across the industry.

AbbVie and Capsida Therapeutics are expanding their gene therapy R&D alliance to the eyes. Capsida is in line to receive $70 million now and up to $595 million later, depending on the progress of the eye programs.

Blue Shield of California's Wellvolution platform includes programs for mental health, diabetes reversal, addiction and nutrition. Last month, the payer made the platform available to its Medi-Cal members, a process that took two years.

To drive adoption, digital health solutions must solve real user problems, which means users cannot be an afterthought in developing these solutions. But it’s also important to recognize that end users aren’t the only group whose needs matter. Workable, scalable digital health solutions must also clear the hurdles of technical feasibility and business viability.

Physicians Health Plan of Northern Indiana and Premise Health will build a primary care center in Fort Wayne, Indiana, that will be exclusive to the health plan's fully-insured members in the area. Members will gain access to a care team that comprises physicians, nurse practitioners, a behavioral health specialist and medical assistants.

The future of healthcare means more home-based care. By taking steps now to embrace this shift, health plans will set the pace for supporting patients in the place where they most want to receive care.

Travere Therapeutics drug Filspari won accelerated FDA approval to treat a rare disorder that can lead to kidney failure. The small molecule is also in late-stage testing for another rare kidney disease; analysts say each indication represents a blockbuster opportunity.

David Finn, CHIME Association Executive Healthcare and Information Sector, lead of the cybersecurity pavilion initiatives at ViVE 2023, does not mince words. With ransomware attacks surging to an all time high this month, Finn said in an interview that security is no longer a defensive posture; we are engaged in a war.